Limited Impact of Anti-PD-1/PD-L1 Monotherapy for Hepatocellular Carcinoma

類似資料

• Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular Carcinoma
  著者:: Tomoko Aoki, 等
  出版事項: (2021-08-01)
• Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody
  著者:: Masahiro Morita, 等
  出版事項: (2021-06-01)
• Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
  著者:: Satoru Hagiwara, 等
  出版事項: (2021-11-01)
• Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations
  著者:: Tomoko Aoki, 等
  出版事項: (2023-10-01)
• Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway
  著者:: Tomoko Aoki, 等
  出版事項: (2025-07-01)